Methyl 2-bromo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate

Catalog No. :
ACKZHN059
CAS No. :
1795232-59-5
Molecular Formula :
C8H6BrN3O2
Molecular Weight :
256.06

IUPAC Name:methyl 2-bromo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate

Methyl 2-bromo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$95.00Login to see priceIn stockIn stock
250mg98%$161.00Login to see priceIn stockIn stock
1g98%$446.00Login to see priceIn stockIn stock
5g98%$1560.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-bromo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate
IUPAC Namemethyl 2-bromo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate
MDL No.MFCD26131656
Molecular FormulaC8H6BrN3O2
Molecular Weight256.06
SMILESO=C(C1=CN2C(C=C1)=NC(Br)=N2)OC
InChI KeyHRKNVEBXWJDVFK-UHFFFAOYSA-N
SynonymMethyl 2-bromo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate | 1795232-59-5 | TQR990 | SCHEMBL16781951 | VWC23259 | MFCD26131656 | AS-83771 | CS-0049178 | P18558 | EN300-1698364 | Methyl2-bromo-[1,2,4]triazolo[1,5-a]pyridine-6-carboxylate
CAS No.1795232-59-5
PubChem CID118129997

Synthetic Route by SureRoute

1. ACKZHN059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAXCK953 route compound structure diagram
    ACAXCK9531094107-41-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKZHN059 route product structure diagram
    ACKZHN0591795232-59-5 In Stock
Inquiry

2. ACKZHN059 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. ACAKJZ082 route compound structure diagram
    ACAKJZ0821784165-37-2 In Stock
  4. Then
  5. ACKZHN059 route product structure diagram
    ACKZHN0591795232-59-5 In Stock
Inquiry

Comments (0)